“港澳药械通”指定医疗机构再扩容

Core Points - The Guangdong Provincial Health Commission and the Guangdong Provincial Drug Administration have released the fourth batch of designated medical institutions under the "Hong Kong-Macao Medical Device and Drug Access" policy, bringing the total to 71 institutions [1] - A total of 140 types of Hong Kong and Macao drugs and medical devices have been approved for use, benefiting approximately 17,000 patients [1] - The policy allows designated medical institutions in the Greater Bay Area to use urgently needed drugs and advanced medical devices that have been approved in Hong Kong and Macao [1] Group 1 - The fourth batch of designated medical institutions includes 27 new hospitals, with 44 hospitals passing the qualification review, and one hospital removed due to closure [1] - Notable new hospitals include Southern Medical University Zhujiang Hospital, Guangzhou Medical University Affiliated Brain Hospital, and Guangdong Second People's Hospital [1] - The "Hong Kong-Macao Medical Device and Drug Access" initiative was officially implemented in 2021, with three previous batches of designated institutions announced in August 2021, February 2023, and September 2024 [2] Group 2 - Local administrative departments are required to strengthen supervision and management of designated medical institutions [2] - Designated institutions are encouraged to deepen cooperation with Hong Kong and Macao in medical services and clinical research [2] - The initiative aims to ensure that imported Hong Kong and Macao medical devices and drugs are used solely for specific medical purposes within the institutions, ensuring safety in their use [2]